{"data":{"event":{"id":"3a589dac-5512-475f-8143-8fdc169f4026","slug":"stat-what-a-vote-on-grail-s-cancer-detection-test-could-mean-for-the-com-612bb4e2be","title":"STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators","short_summary":"Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.","full_description":"Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.\n\nUpdate (2026-09-23): STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks. An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.","ledger_type":"benefit","primary_domain_id":"c09546b6-10f8-48df-8347-0c1979416464","event_status":"provisional","event_date":"2026-09-21T00:00:00.000Z","discovery_date":"2026-09-21T00:00:00.000Z","first_published_date":"2026-09-21T00:00:00.000Z","last_reviewed_date":"2026-09-23T00:00:00.000Z","geographic_scope":"International","affected_population":null,"base_impact_tier":1,"base_score":"1.00","attribution_multiplier":"0.1000","evidence_multiplier":"0.2000","realization_multiplier":"0.2000","durability_multiplier":"0.5000","current_event_score":"0.002000","confidence_level":"low","score_explanation":"Ingest update: independent source raised evidence; added a follow-up source. Score remains provisional until review.","methodology_version_id":"8745541b-0f8e-4d5a-9b47-5291d3813a8d","original_methodology_version_id":"8745541b-0f8e-4d5a-9b47-5291d3813a8d","published_at":"2026-09-21T18:01:09.871Z","created_at":"2026-09-21T18:01:09.871Z","updated_at":"2026-09-23T22:01:03.603Z","flags":[],"domain_name":"Medicine & Health","domain_slug":"medicine-health","methodology_version":"0.2"},"contributions":[{"id":"34ad337e-35ad-4885-bb7c-ec820c5c1ace","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","model_id":"535014f7-c941-4d39-aa9b-8f9c1d3d07b7","role_description":"Unspecified system mentioned or implied by a news item. Remap to a named release when identified.","attribution_multiplier":"0.1000","credit_share":"1.0000","contribution_score":"0.002000","attribution_rationale":"News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.","attribution_confidence":"medium","first_used_date":"2026-09-21T00:00:00.000Z","model_version_if_known":null,"review_status":"approved","created_at":"2026-09-21T18:01:09.880Z","model_slug":"unspecified-ai-system","model_name":"Unspecified AI system","identity_class":"unknown","is_internal":false,"family_name":"Unspecified","family_slug":"unknown-unspecified","organization_name":"Unknown","organization_slug":"unknown"}],"sources":[{"id":"a8396b5b-7bd8-492a-bfc7-9c64bc350ab3","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","url":"https://www.statnews.com/2026/09/21/grail-galleri-fda-advisory-committee-meeting-documents/?utm_campaign=rss","canonical_url":"https://www.statnews.com/2026/09/21/grail-galleri-fda-advisory-committee-meeting-documents/?utm_campaign=rss","source_type":"journalism","publisher":"STAT","author":null,"publication_date":"2026-09-21T00:00:00.000Z","retrieved_at":"2026-09-21T18:01:09.890Z","title":"STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators","excerpt":"Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.","content_hash":null,"source_reliability_class":"medium","is_primary_source":true,"is_independent":true,"is_peer_reviewed":false,"archived_url":null,"created_at":"2026-09-21T18:01:09.890Z"},{"id":"b7e9463a-4d64-4afd-8365-1aca08708d27","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","url":"https://www.statnews.com/2026/09/23/fda-advisory-panel-recommends-approval-grail-galleri-multi-cancer-blood-test/?utm_campaign=rss","canonical_url":"https://www.statnews.com/2026/09/23/fda-advisory-panel-recommends-approval-grail-galleri-multi-cancer-blood-test/?utm_campaign=rss","source_type":"journalism","publisher":"STAT","author":null,"publication_date":"2026-09-23T00:00:00.000Z","retrieved_at":"2026-09-23T22:01:03.545Z","title":"STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks","excerpt":"An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.","content_hash":null,"source_reliability_class":"medium","is_primary_source":false,"is_independent":false,"is_peer_reviewed":false,"archived_url":null,"created_at":"2026-09-23T22:01:03.545Z"}],"claims":[{"id":"38131f78-6b07-4bfc-ae27-fe54cf4ee6e7","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","claim_text":"STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators","claim_type":"outcome","claim_status":"supported","confidence_score":null,"created_at":"2026-09-21T18:01:09.897Z","updated_at":"2026-09-21T18:01:09.897Z"}],"revisions":[{"id":"fd8d7d76-2255-432f-985f-2f0ea62b132f","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","model_id":null,"previous_score":"0.000000","new_score":"0.001000","previous_factors":{},"new_factors":{"tier":1,"evidence":0.1,"base_score":1,"durability":0.5,"attribution":0.1,"realization":0.2},"change_reason":"Auto-published from news ingest.","trigger_type":"news_ingest","trigger_source_ids":null,"reviewer_id":null,"review_status":"published","created_at":"2026-09-21T18:01:09.906Z"},{"id":"c22a7152-1b86-4620-8334-db06732ef107","event_id":"3a589dac-5512-475f-8143-8fdc169f4026","model_id":null,"previous_score":"0.001000","new_score":"0.002000","previous_factors":{"tier":1,"evidence":0.1,"base_score":1,"durability":0.5,"attribution":0.1,"realization":0.2},"new_factors":{"tier":1,"models":["535014f7-c941-4d39-aa9b-8f9c1d3d07b7"],"evidence":0.2,"base_score":1,"durability":0.5,"attribution":0.1,"realization":0.2},"change_reason":"Ingest update: independent source raised evidence; added a follow-up source.","trigger_type":"ingest_update","trigger_source_ids":["b7e9463a-4d64-4afd-8365-1aca08708d27"],"reviewer_id":null,"review_status":"published","created_at":"2026-09-23T22:01:03.611Z"}],"secondary":[]},"methodology_version":"0.1"}